Insights

Expansion Opportunities Neurogene recently expanded its facilities to Houston, Texas, indicating potential growth in demand for genetic medicines in that region. This expansion presents an opportunity for partnerships, collaborations, and sales strategies to tap into the emerging market.

Strategic Financial Position With successful financing rounds totaling $200 million in PIPE financing and $95 million in private financing, Neurogene is in a strong financial position. This could be leveraged to explore new markets, invest in research and development of cutting-edge genetic therapies, and potentially acquire resources or companies to enhance its product offerings.

Key Personnel Additions The recent addition of experienced professionals like Donna Cochener as Senior Vice President, General Counsel, and Julie Jordan as Chief Medical Officer, strengthens Neurogene's leadership team. Leveraging the expertise of such key personnel can boost sales efforts, drive strategic partnerships, and enhance the company's overall market positioning.

Strategic Partnerships By partnering with Neoleukin Therapeutics and collaborating with the University of Rochester, Neurogene has demonstrated a commitment to strategic alliances. These partnerships can open doors for joint research initiatives, cross-selling opportunities, and access to new customer segments, ultimately driving sales growth.

Competitive Analysis Insight Analyzing similar companies like Orchard Therapeutics, Passage Bio, and Sarepta Therapeutics, Neurogene can gain insights into market trends, competitive positioning, and potential areas for differentiation. Understanding the competitive landscape can help tailor sales strategies, product positioning, and pricing to effectively compete and capture market share.

Neurogene Inc. Tech Stack

Neurogene Inc. uses 8 technology products and services including SAS, W3 Total Cache, SAP, and more. Explore Neurogene Inc.'s tech stack below.

  • SAS
    Business Intelligence
  • W3 Total Cache
    Caching
  • SAP
    Customer Relationship Management
  • MySQL
    Database
  • NetSuite
    E-commerce
  • Microsoft
    Miscellaneous
  • Ubuntu
    Operating Systems
  • Microsoft Azure
    Platform As A Service

Media & News

Neurogene Inc.'s Email Address Formats

Neurogene Inc. uses at least 1 format(s):
Neurogene Inc. Email FormatsExamplePercentage
First.Last@neurogene.comJohn.Doe@neurogene.com
96%
First.Middle@neurogene.comJohn.Michael@neurogene.com
2%
Last.First@neurogene.comDoe.John@neurogene.com
1%
FLast@neurogene.comJDoe@neurogene.com
1%

Frequently Asked Questions

Where is Neurogene Inc.'s headquarters located?

Minus sign iconPlus sign icon
Neurogene Inc.'s main headquarters is located at 535 W 24th St 5th Floor New York, New York 10011 US. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is Neurogene Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Neurogene Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Neurogene Inc.'s stock symbol?

Minus sign iconPlus sign icon
Neurogene Inc. is a publicly traded company; the company's stock symbol is NGNE.

What is Neurogene Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Neurogene Inc.'s official website is neurogene.com and has social profiles on LinkedIn.

How much revenue does Neurogene Inc. generate?

Minus sign iconPlus sign icon
As of February 2025, Neurogene Inc.'s annual revenue reached $35M.

What is Neurogene Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Neurogene Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Neurogene Inc. have currently?

Minus sign iconPlus sign icon
As of February 2025, Neurogene Inc. has approximately 107 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: R. M.Chief Medical Officer: J. C. J.Chief Medical Officer: E. E. A.. Explore Neurogene Inc.'s employee directory with LeadIQ.

What industry does Neurogene Inc. belong to?

Minus sign iconPlus sign icon
Neurogene Inc. operates in the Biotechnology Research industry.

What technology does Neurogene Inc. use?

Minus sign iconPlus sign icon
Neurogene Inc.'s tech stack includes SASW3 Total CacheSAPMySQLNetSuiteMicrosoftUbuntuMicrosoft Azure.

What is Neurogene Inc.'s email format?

Minus sign iconPlus sign icon
Neurogene Inc.'s email format typically follows the pattern of . Find more Neurogene Inc. email formats with LeadIQ.

How much funding has Neurogene Inc. raised to date?

Minus sign iconPlus sign icon
As of February 2025, Neurogene Inc. has raised $184M in funding. The last funding round occurred on Dec 16, 2020 for $115M.

When was Neurogene Inc. founded?

Minus sign iconPlus sign icon
Neurogene Inc. was founded in 2018.
Neurogene Inc.

Neurogene Inc.

Biotechnology ResearchNew York, United States51-200 Employees

Neurogene is accelerating development of new genetic medicines to people with devastating neurological diseases and their families. To do this, we are working with experts across the globe to advance a broad pipeline of programs to treat the underlying cause of serious neurological disorders and thereby address the overwhelming need for new therapies.

Although the human genome was sequenced for the first time nearly 20 years ago, the true genomics revolution is taking place now, providing us with the ability to radically alter rare, genetic disorders. At Neurogene, we are working to provide medicines to improve the lives of neurologically-impaired and developmentally-delayed children and their families.

We are building a team of passionate, driven individuals who envision a world in which all families have access to genetic medicines, even if the disorder is exceedingly rare. 

To learn more, please visit http://www.neurogene.com/careers/.

Section iconCompany Overview

Headquarters
535 W 24th St 5th Floor New York, New York 10011 US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
NGNE
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
51-200

Section iconFunding & Financials

  • $184M

    Neurogene Inc. has raised a total of $184M of funding over 2 rounds. Their latest funding round was raised on Dec 16, 2020 in the amount of $115Mas a series B.

  • $10M$50M

    Neurogene Inc.'s revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $184M

    Neurogene Inc. has raised a total of $184M of funding over 2 rounds. Their latest funding round was raised on Dec 16, 2020 in the amount of $115Mas a series B.

  • $10M$50M

    Neurogene Inc.'s revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.